잠시만 기다려 주세요. 로딩중입니다.

Robotic Total Mesorectal Excision for Rectal Cancer: Current Evidences and Future Perspectives

Annals of Coloproctology 2020년 36권 5호 p.293 ~ 303
장제호, 김창남,
소속 상세정보
장제호 ( Jang Je-Ho ) - Eulji University School of Medicine Department of Surgery
김창남 ( Kim Chang-Nam ) - Eulji University School of Medicine Department of Surgery

Abstract


Despite the technical limitations of minimally invasive surgery, laparoscopic total mesorectal excision (LTME) for rectal cancer has short-term advantages over open surgery, but the pathological outcomes reported in randomized clinical trials are still in controversy. Minimally invasive robotic total mesorectal excision (RTME) has recently been gaining popularity as robotic surgical systems potentially provide greater benefits than LTME. Compared to LTME, RTME is associated with lower conversion rates and similar or better genitourinary functions, but its long-term oncological outcomes have not been established. Although the operating time of RTME is longer than that of LTME, RTME has a shorter learning curve, is more convenient for surgeons, and is better for sphincter-preserving operations than LTME. The robotic surgical system is a good technical tool for minimally invasive surgery for rectal cancer, especially in male patients with narrow deep pelvises. Robotic systems and robotic surgical techniques are still improving, and the contribution of RTME to the treatment of rectal cancer will continue to increase in the future.

키워드

Rectal neoplasms; Total mesorectal excision; Robotic surgical procedures

원문 및 링크아웃 정보

등재저널 정보